Malnutrition in Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 21, Issue 2, 1993, Pages 125-137

  Hakim, Raymond M ^a,b   Levin, Nathan ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

albumin; biocompatibility; dose of dialysis; growth hormone; Malnutrition

Indexed keywords

ERYTHROPOIETIN; GROWTH HORMONE; METOCLOPRAMIDE; SERUM ALBUMIN; SOMATOMEDIN C; TRANSFERRIN;

BODY COMPOSITION; DIALYSIS MEMBRANE; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; MALNUTRITION; MORBIDITY; MORTALITY; NAUSEA; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN RESTRICTION; REVIEW; SOCIOECONOMICS; UREMIA;

EID: 0027478389     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)81083-3     Document Type: Article

References (109)

1. Anthropometric norms for the dialysis population
2. Protein calorie malnutrition and cutaneous energy in hemodialysis maintained patients
3. Malnutrition, altered immune function and the risk of infection in maintenance hemodialysis patients
4. Reversal of skin test anergy during maintenance hemodialysis by protein and calorie supplementation
5. Methods for assessing nutritional status of patients with renal failure
6. Simple methods for nutritional assessment in hemodialyzed patients
7. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
8. Albumin turnover in chronically hemodialyzed patients
9. The affects of calorie and essential amino acid supplementation on plasma proteins in patients with chronic renal failure
10. Malnutrition in hemodialysis patients
11. Serum transferrin levels in chronic renal failure
12. 1GF-I, a marker of undernutrition in hemodialysis patients
13. Muscle biopsy studies in chronically uremic patients: Evidence for malnutrition
14. Mortality risk factors in patients treated by chronic hemodialysis
15. Nitrogen balance during intermittent dialysis therapy of uremia
16. Standards for dialysis adequacy
17. Control of dialysis by singlepool urea model. The National Cooperative Dialysis Study
18. The post:pre dialysis plasma urea nitrogen ratio to estimate Kt/V and NPCR: Validation
19. Assessment of nutritional status of the National Cooperative Dialysis Study population
20. The role of urea kinetic modeling, TACurea, and Kt/V in achieving optimal dialysis: A critical reappraisal
21. Kinetic modelling in hemodialysis
22. Practical considerations for urea kinetic modeling in nutritional assessment
23. Lean body mass estimation from creatinine kinetics
24. Body protein of patients undergoing haemodialysis
25. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition
26. Nutritional status and mortality of patients in regular dialysis therapy
27. Importance of nutrition in dialysis patients
28. Nutritional status of patients on hemodialysis and peritoneal dialysis
29. Prolonged hyperalimentation in catabolic chronic dialysis therapy patients
30. Cross-sectional and longitudinal measurements in maintenance hemodialysis patients
31. Methods for assessing nutritional status of patients with renal failure
32. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly
33. Anthropometry and plasma valine, amino acids, and proteins in the nutritional assessment of hemodialysis patients
34. Protein metabolism and nutrition in hemodialysis patients
35. Effectiveness of intradialytic parenteral nutrition in diabetic patients with endstage renal disease
36. Total-body nitrogen by neutron activation in maintenance dialysis
37. Causes of catabolism and wasting in acute or chronic renal failure
38. Protein energy malnutrition in patients undergoing regular haemodialysis
39. Incidence and sequelae of malnutrition in chronic hemodialysis patients
40. Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal
41. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients
42. Nutritional status and lymphocyte function in maintenance hemodialysis patients
43. Malnutrition is lethal, diagnosable, and treatable in ESRD patients
44. Comorbid factors are not the reason for hypoalbuminemia in incident hemodialysis (HD) patients
45. Uremia and the control of protein metabolism
46. Protein catabolic factors in patients on renal replacement therapy
47. Nutritional status of patients with different levels of chronic renal insufficiency
48. Gastrointestinal function, morphology, and immune status in uremia
49. A method for estimating nitrogen intake of patients with chronic renal failure
50. Biochemical parameters in chronic renal failure
51. Protein and amino acid metabolism in uremia: influence of metabolic acidosis
52. Review: Mechanisms for abnormal protein metabolism in uremia
53. Inhibitors of protein synthesis in uremic serum and urine
54. Nutritional requirements of hemodialysis patients
55. Effects of renal insufficiency on nutrient metabolism and endocrine function
56. Insulin resistance in uremia
57. Hypoglycemia associated with renal failure
58. The influence of hyperparathyroidism on glucose metabolism in uremia
59. Role of parathyroid hormone in the glucose intolerance of chronic renal failure
60. Nutritional assessment and treatment of chronic renal failure
61. Protein requirements in maintenance hemodialysis
62. Optimal dietary protein treatment during chronic hemodialysis
63. The effect of interdialytic interval on protein metabolism: Evidence suggesting dialysis-induced catabolism
64. Amino acid losses during hemodialysis with infusion of amino acids and glucose
65. The free and bound amino acids removed by hemodialysis
66. Amino acid losses during high-flux versus conventional hemodialysis in patients receiving parenteral nutrition
67. Protein catabolic factors in patients on renal replacement therapy
68. A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients
69. Nutritional aspects ofleukocytic cytokines
70. Survival and adequacy in longterm hemodialysis
71. Adequacy of hemodialysis
72. Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients
73. The efficacy of nutrition support in infected patients with chronic renal failure
74. Effects of catabolic stress in acute and chronic renal failure
75. Nutritional and metabolic response to catabolic stress in uremia
76. Hospitalized dialysis patients have lower nutrient intakes on renal diet than on regular diet
77. Nutritional management of the chronic hemodialysis patient
78. Increasing dose of dialysis improves mortality and nutritional parameters in hemodialysis (HD) patients
79. Nutritional support in renal failure
80. Aggressive nutritional supplementation in chronic hemodialysis patients
81. Tube feeding in children on chronic peritoneal dialysis
82. Tube feeding in the real world: Formulas, equipment, finances, and feeding problems
83. Isotonic tube feeding formula induces liquid stool in normal subjects: Reversal by pectin
84. Percutaneous gastrojejunostomy for caloric supplementation in children on peritoneal dialysis
85. Translumbar duodenostomy for enteral feeding
86. Intradialytic parenteral nutrition as a therapy for malnourished hemodialysis patients
87. Intradialytic parenteral nutrition in chronic hemodialysis patients
88. Predialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients
89. Effectiveness of intradialytic parenteral nutrition in diabetic patients with endstage renal disease
90. Intradialytic parenteral nutrition
91. Indications for the use of intradialytic parenteral nutrition in the malnourished hemodialysis patient
92. Erythropoietin-induced changes in protein nutrition: quantitative assessment by urea kinetic modeling analysis
93. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin
94. Correction of amino acid metabolism by recombinant EPO in hemodialysis patients
95. EPO and renal nutrition—One year later. Evidence lacking in appetite improvement
96. EPO and renal nutrition—One year later. Evidence lacking in appetite improvement
97. EPO and renal nutrition—One year later. Evidence lacking in appetite improvement
98. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis
99. Growth hormone and insulin-like growth factor I in chronic renal failure—Pathophysiology and rationale for growth hormone treatment
100. Response to growth hormone-releasing hormone in adult renal failure patients on hemodialysis
101. The influence of recombinant human growth hormone and intradialytic parenteral nutrition on malnutrition parameters of hemodialysis patients
102. Catabolic illness strategies for enhancing recovery
103. Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition
104. Improvement of growth and food utilization by human recombinant growth hormone in uremia
105. Recombinant human growth hormone treatment of children with chronic renal failure: Long-term (1 to 3 year) outcome
106. Which comes first, Kt/V or PCR—Chicken or egg?